PGHL5,435.00

Procter & Gamble Health Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersSANOFICONRSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹9,022 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
30/06/2024
FY26
30/06/2025
FY27
30/06/2026
Revenue from Operations1,151.3338.7363.7
Other Income15.64.03.9
Total Income1,166.9342.8367.6
Expenses
+ Cost of Materials Consumed290.259.580.3
+ Purchases of Stock-in-Trade39.524.324.6
+ Changes in Inventories0.910.1-8.7
+ Employee Benefit Expense215.256.060.4
+ Finance Costs0.70.10.1
+ Depreciation & Amortisation27.45.46.0
+ Other Expenses299.598.4107.5
Total Expenses873.4254.0270.3
EBITDA306.090.399.6
EBIT278.684.993.6
Profit
PBT before Exceptional Items293.588.897.3
+ Exceptional Items-20.20.031.8
Pretax Income273.388.8129.1
+ Current Tax80.922.931.0
+ Deferred Tax-8.6-0.31.9
Tax Expense72.322.633.0
Net Income201.066.296.2
+ Net Income — Continuing Ops201.066.296.2
+ Other Comprehensive Income0.7-0.70.3
Total Comprehensive Income201.765.596.5
Per Share
Basic EPS121.0739.8757.92
Diluted EPS121.0739.8757.92
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.70.3
+ Items NOT to be Reclassified to P&L0.9-0.90.4
+ Tax on Items NOT to be Reclassified-0.20.1
+ Tax on Items NOT to be Reclassified — alt tag0.2
Per Share — as-filed variants
Basic EPS — Continuing Operations121.0739.8757.92
Diluted EPS — Continuing Operations121.0739.8757.92
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit820.7244.8267.5
Gross Margin %71.2972.2573.54
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)293.588.897.3
− Exceptional Items (reconciliation)-20.20.031.8
Net Income Adj (tax-effected)215.866.272.5
EPS Adj130.0139.8743.66
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.00
Paid Up Equity Capital16.616.616.6
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.